Clinical- and Immunological Activity, Safety and Tolerability of Different Doses / Formulations of AFFITOPE AD02 in Early Alzheimer's Disease
Clinical trial NCT01117818 · COMPLETED
Trial details
- NCT number
- NCT01117818
- Sponsor
- Affiris AG
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-09-01
- Primary completion
- 2013-12-01
- Enrollment
- 335
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.